These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. PHARMACOLOGICAL TREATMENT OF CHILDREN WITH GASTRO-ESOPHAGEAL REFLUX: A SUMMARY. Gaines C Gastroenterol Nurs; 2016; 39(1):68-70. PubMed ID: 26825568 [No Abstract] [Full Text] [Related]
9. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Lee JS; Ryu JH; Elicker BM; Lydell CP; Jones KD; Wolters PJ; King TE; Collard HR Am J Respir Crit Care Med; 2011 Dec; 184(12):1390-4. PubMed ID: 21700909 [TBL] [Abstract][Full Text] [Related]
15. Medical management vs. surgery for gastroesophageal reflux disease. Kripke C Am Fam Physician; 2010 Aug; 82(3):244. PubMed ID: 20672787 [No Abstract] [Full Text] [Related]
16. Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter? Schnoll-Sussman F; Katz PO Aliment Pharmacol Ther; 2015 Sep; 42(5):626. PubMed ID: 26238577 [No Abstract] [Full Text] [Related]
17. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor. Juul-Hansen P; Rydning A Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541 [TBL] [Abstract][Full Text] [Related]
18. Medical therapy for gastroesophageal reflux disease in 2007. Katz PO Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955 [TBL] [Abstract][Full Text] [Related]
19. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease]. Kawai T; Yagi K; Moriyasu F Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073 [TBL] [Abstract][Full Text] [Related]
20. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. Malcolm WF; Cotten CM Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]